Overexpression of Farnesyl Pyrophosphate Synthase Increases Myocardial Ischemia/reperfusion Injury in Mice.

Dongpu Dai,Xiaotong Sun,Jie Ding,Yuxiao Chen,Shenjiang Hu
DOI: https://doi.org/10.1016/j.gene.2018.05.116
IF: 3.913
2018-01-01
Gene
Abstract:Farnesyl pyrophosphate synthase (FPPS) is a vital enzyme in the mevalonate pathway. Our previous study has indicated that overexpression of FPPS increases hypoxia/reoxygenation (HR) injury in Heart-derived H9c2 Cells. Hence, we designed this experiment to further investigate the effect of FPPS on myocardial ischemia/reperfusion (MIR) injury using a transgenic (Tg) model, and explore the relevant mechanisms. The results showed that when mouse hearts were subjected to ex vivo I/R, Tg mice have a higher CK and LDH, a larger myocardial infarct size and lower heart function recovery. These phenomena are associated with the increased Rac1 activity and ROS generation. These findings point to that FPPS might be a potential target in preventing MIR in vivo.
What problem does this paper attempt to address?